Clark, CR; DeRuiter, J. Analytical and synthetic studies on designer drugs of the piperazine class, US DOJ, 1 Dec 2014. 15.6 MB. #2-OMePP MS
Takahashi, M; Nagashima, M; Suzuki, J; Seto, T; Yasuda, I; Yoshida, T. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry Talanta, 15 Feb 2009, 77 (4), 1245–1272. 1.2 MB. https://doi.org/10.1016/j.talanta.2008.07.062 #2MPP GC,LC,MS,UV
Bishop, SC; McCord, BR; Gratz, SR; Loeliger, JR; Witkowski, MR. Simultaneous separation of different types of amphetamine and piperazine designer drugs by capillary electrophoresis with a chiral selector J. Forensic Sci., 1 Mar 2005, 50 (2), 1–10. 597 kB. https://doi.org/10.1520/JFS2004239 #oMeOPP LC,MS,UV,other
Nishimura, Y; Tanaka, S; Ikeda, H; Yamazaki, Y. Study of method for identifying regioisomers of controlled drugs JCCL, 1 Dec 2015, (55), 65–85. 707 kB. #2-MPP Japanese, English abstract GC,MS,UV
Lyon, RA; Titeler, M; McKenney, JD; Magee, PS; Glennon, RA. Synthesis and evaluation of phenyl- and benzoylpiperazines as potential serotonergic agents J. Med. Chem., 1 May 1986, 29 (5), 630–634. 1.2 MB. https://doi.org/10.1021/jm00155a008 #3a NMR,IR,other